secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001628280-23-004295
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q4 revenue down 10.7% to $337.2M; guides Q1 revenue $300-320M
----------------------------------------------------------------------

- Q4 GAAP EPS $2.41, adjusted EPS $3.70; net income $26.5M vs $34.0M YoY.
- Full-year 2022 revenue up 4.8% to $1.6B; GAAP EPS $12.73, adjusted EPS $14.50.
- Active earning OPTA VIA Coaches 60,900 (+1.8% YoY); revenue per coach $5,538 (-12.4%).
- Q1 2023 guidance: revenue $300-320M, diluted EPS $1.75-2.40; assumes 26-27% tax rate.
- Cash $87.7M, no debt; quarterly dividend of $1.64/share paid Feb 7, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828023004295/0001628280-23-004295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828023004295/med-20230221.htm
  HTML page:      https://secwatch.observer/filing/0001628280-23-004295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer